Login
From:
Lupus News Today
(Uncensored)
subscribe
FDA OKs Phase 1 study of two-component immunotherapy
https://lupusnewstoday.com/news/fda-oks-phase-1-study-two-component-immunotherapy/
links
backlinks
The FDA approved the launch of a clinical trial to evaluate the safety and effectiveness of its two-component immunotherapy for lupus.
Roast topics
Find topics
Find it!
